Semaglutide is a GLP-1 analog that can stimulate the human pancreas to secrete insulin and inhibit the secretion of glucagon, thereby achieving the goal of blood sugar control. This product is a biologically prepared semaglutide main chain, structured as an intermediate peptide composed of 29 amino acids. CAS NO:1169630-82-3(Purity:≥95%).